Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation

作     者：马瑞 MA Rui

作者机构：Peking Univ People’s HospPeking Univ Instit HematolNatl Clin Hematol Dis Res CenterBeijing Key LabHematopoietic Stem Cell TransplantBeijing 100044 

出 版 物：《China Medical Abstracts(Internal Medicine)》 (中国医学文摘（内科学分册（英文版）)

年 卷 期：2023年第40卷第4期

页      面：232-232页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：hematopoietic prevention infection 

摘      要：Objective To analyze the efficacy and safety of letermovir in primary prophylaxis of cytomegalovirus(CMV)reactivation in patients receiving haploidentical hematopoietic stem cell *** This retrospective,cohort study was conducted using data of patients who underwent haploidentical transplantation at Peking University Institute of Hematology and received letermovir for primary prophylaxis between May 1。